A university-industry collaborative research has provided scientific evidence confirming the beneficial effects of "Bak Foong Pills" (BFP), or White Phoenix Pills, the researchers announced here Friday.
Researchers from the Chinese University of Hong Kong (CUHK) said the technology and methodology adapted by the research team may facilitate further researches in traditional Chinese medicine, benefiting the Hong Kong industry as a whole.
With a better understanding of the pharmacological actions of BFP, the researchers also proposed a new formula for treating postmenopausal syndromes.
BFP is a health product for women based on a century-old traditional formula in China.
The 9.28 million-HK dollar (US$1.19 million) research was jointly funded by Hong Kong health-care company Eu Yan Sang Group and the Innovation and Technology Fund under the Innovation and Technology Commission of the Hong Kong Special Administrative Region government.
Commenced in June 2000, it was undertaken by the Epithelial Cell Biology Research Center of the CUHK.
(Xinhua News Agency December 7, 2002)
